colitis and glp-1 The alleviating effect mechanism of on ulcerative Weight Loss Medications & IBD

These findings expand upon the growing body of literature raising concerns regarding the potential ocular safety of systemic GLP-1 RA use in patients with diabetes, investigators concluded

Glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: an update

After reviewing your medical history and discussing your goals, we will determine the optimal dosage tailored to your needs

Heres what you can do: Dos: Eat slowly during meals Eat bland, low-fat foods Eat foods with high water content, like Jell-O or soup Drink ginger or peppermint tea Inject the medication in the evening Donts: Lie down immediately after eating Eat overly spicy, greasy, or sugary foods Indigestion Because GLP-1 medications slow digestion, food may sit in the stomach longer, causing discomfort

Tirzepatide is administered subcutaneously once weekly, with dosing typically initiated at 2.5 mg and gradually titrated upward based on therapeutic response and tolerability